The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Standardization of Cystatin C: development of primary and secondary reference preparations.

Author

Summary, in English

A Primary Reference Preparation has been produced using pure, recombinant, Cystatin C in a solvent of 0.1 mol/L KCl. Dry mass determination of the Primary Reference Preparation resulted in a Cystatin C concentration of 5.20 g/L. Agarose-electrophoresis and SDS-electrophoresis, as well as N-terminal sequencing, verified the purity, homogeneity and identity of Cystatin C in the Primary Reference Preparation. For the Secondary Reference Preparation, a serum pool was collected and stabilized. A pilot batch was made to verify the selected procedure and spiking with the pure, recombinant Cystatin C. The final Secondary Reference Preparation is now produced (4468 vials) and ready for value assignment and further characterization.

Publishing year

2008

Language

English

Pages

67-70

Publication/Series

Scandinavian Journal of Clinical & Laboratory Investigation

Volume

68

Issue

s241

Document type

Journal article

Publisher

Informa Healthcare

Topic

  • Medicinal Chemistry
  • Pharmacology and Toxicology

Keywords

  • Primary Reference Preparation
  • Secondary Reference Preparation
  • standardization of Cystatin C
  • dry mass determination
  • Cystatin C

Status

Published

ISBN/ISSN/Other

  • ISSN: 1502-7686